By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on Rigetti's stock, with the $100 million CHIPS Act grant extending runway but not guaranteeing revenue. The equity stake taken by the government is seen as a significant risk, potentially diluting shareholders and creating governance constraints.
Risk: Government equity stake creating dilution and governance constraints
Opportunity: Potential accelerated DoD procurement (speculative)
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The U.S. Department of Commerce will award Rigetti Computing $100 million to research quantum miniaturization.
Rigetti will burn through that cash in 15 months.
Yesterday, as you've probably heard, The Wall Street Journal reported on a Trump Administration plan to award $2 billion to nine quantum computing companies -- Rigetti Computing (NASDAQ: RGTI) among them -- and to take government equity stakes in the companies in return. Rigetti shares started moving one day before the announcement was made, then rocketed higher yesterday -- and higher again today.
Up 18% through 10:55 a.m. Friday morning, Rigetti shares have gained an astounding 63% in just three days of trading, and investors are wondering: Is any price too high to pay for this quantum computing stock?
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Shortly after WSJ broke the story, the U.S. Department of Commerce confirmed that not only does it plan to award grants, but it has in fact already signed letters of intent to do so.
Operating under the CHIPS and Science Act, Commerce will "support and accelerate critical research and manufacturing of technologies for the quantum ecosystem to ensure continued United States leadership and national security." Two quantum foundries, Globalfoundries (NASDAQ: GFS) and International Business Machines (NYSE: IBM), will receive $375 million and $1 billion, respectively.
Rigetti and five others will receive $100 million apiece, and the ninth company will receive $38 million. Each of the seven non-foundry recipients will focus on specific technologies needed to build quantum computers. Rigetti in particular will focus on miniaturization and cryostat devices for maintaining extremely low temperatures.
The question now is how much good even this money can do for Rigetti, which is burning more than $80 million a year. Even if Rigetti gets all of the "up to $100 million" it's allotted, this adds only about 15 months to its lifespan.
Rigetti's not out of the woods yet.
Before you buy stock in Rigetti Computing, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rigetti Computing wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $481,589! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,345,714!
Now, it’s worth noting Stock Advisor’s total average return is 993% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 22, 2026. *
Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends GlobalFoundries and International Business Machines. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The grant extends Rigetti's runway by only about 15 months without solving its core commercialization and dilution risks."
Rigetti's $100 million CHIPS Act grant for quantum miniaturization and cryostats buys roughly 15 months of runway given its >$80 million annual cash burn, yet the stock's 63% three-day surge ignores that this is pre-revenue technology with multi-year commercialization timelines. The award includes undisclosed government equity stakes that could dilute shareholders, while larger allocations to IBM and GlobalFoundries underscore Rigetti's niche positioning. Momentum from the WSJ leak may fade once investors price in dilution and execution risks rather than the headline alone.
The grant could attract follow-on private capital or defense contracts that extend viability well beyond the initial 15 months and validate Rigetti's miniaturization approach against larger competitors.
"A 15-month runway extension on $80M annual burn is a lifeline, not a thesis—the stock's 63% rally prices in success that still requires converting R&D into defensible, revenue-generating products before cash runs out."
The article conflates grant receipt with business viability. Rigetti burns $80M+ annually; a $100M grant extends runway by ~15 months—the article itself admits this. The real question isn't whether the grant is real (it is), but whether miniaturization R&D converts to revenue before cash depletes. The stock surge reflects euphoria over government backing, not a solved unit economics problem. IBM and GFS receiving 10-13x more capital suggests Commerce views them as the actual foundry layer; Rigetti is a component supplier in a nascent ecosystem. Pre-revenue quantum plays are venture-stage risk masquerading as policy tailwinds.
If Rigetti's cryostat tech becomes the bottleneck for U.S. quantum scaling, follow-on contracts and partnerships could materialize faster than the burn rate suggests—and government backing may unlock private capital that wasn't available before.
"The $100 million grant is a survival lifeline that masks the underlying reality of extreme cash burn and inevitable future shareholder dilution."
The market is mispricing this $100 million grant as a revenue windfall rather than a survival bridge. Rigetti (RGTI) is essentially a pre-revenue R&D shop with an $80 million annual burn rate; this infusion merely delays potential dilution for five quarters. While the CHIPS Act validation is a significant signal of national security importance, investors are ignoring the equity stake component mentioned by the WSJ. If the government takes a meaningful equity position, it creates a massive overhang and potential governance constraints. At a 63% three-day gain, the stock is pricing in a commercial breakthrough that remains years away. I see this as a classic 'sell the news' event for retail momentum traders.
The government's equity stake could serve as a 'de facto' floor, signaling that the state will not allow a critical national security asset to go bankrupt, effectively de-risking the long-term insolvency narrative.
"Even with the government grant, Rigetti’s fundamental risk—long commercialization cycles, high burn, and competitive pressure—keeps upside speculative at best and could lead to a pullback if funding is uncertain or milestones falter."
The article frames Rigetti’s $100M grant as a near-term equity-boosting catalyst, given a $80M+ annual burn and ~15 months of runway added. Yet the core risks are glossed: funding is 'up to' $100M with letters of intent signed rather than full contracts, and government equity stakes could cap upside and invite oversight. Quantum hardware remains at a high-uncertainty, long-horizon commercialization stage with fierce competition (IBM, Google, IonQ, GlobalFoundries). Even with funding, the business model, unit economics, and milestone-driven milestones create optionality rather than guaranteed revenue. Momentum moves may reverse if funds aren’t fully deployed or milestones stall.
The upbeat view may overstate the probability of full $100M being granted and the likelihood that this derisks Rigetti’s burn; a partial or delayed grant could spark a liquidity crunch, and equity stakes could dampen upside.
"The grant may unlock DoD procurement revenue faster than commercial timelines allow, mitigating dilution concerns."
Gemini's sell-the-news thesis overlooks how the CHIPS Act's national security framing could trigger accelerated DoD budget allocations for Rigetti's cryostat tech, bypassing typical commercialization lags. This creates a potential revenue bridge via government procurement that private markets alone wouldn't provide, even before full miniaturization milestones. The equity stake might actually accelerate such contracts by aligning incentives rather than capping upside.
"CHIPS Act validation does not automatically convert to DoD procurement; equity dilution and governance constraints are the binding constraint, not the grant itself."
Grok's DoD procurement bridge is speculative—no evidence in the article or public record that CHIPS grants trigger accelerated defense contracts. The 'national security framing' is boilerplate for CHIPS Act justification; it doesn't automatically unlock procurement. Gemini's equity-stake overhang remains the material risk: government ownership typically comes with reporting, milestone gates, and potential veto rights that constrain M&A or pivot optionality. Runway extension ≠ revenue path.
"Government equity stakes in quantum firms function as a de-facto floor that lowers the cost of capital and increases the probability of future non-dilutive funding."
Claude, you’re missing the strategic significance of the equity stake. It isn't just a constraint; it's a 'too big to fail' signal. By taking equity, the government effectively becomes an anchor investor, which drastically lowers the cost of future capital raises. While the DoD procurement bridge Grok mentions is speculative, the government’s role as a shareholder makes future non-dilutive R&D grants far more likely. This shifts the risk profile from pure insolvency to execution-only.
"DoD procurement is speculative; government equity creates governance constraints that can throttle upside beyond any potential grant."
The DoD procurement bridge is speculative; the article notes grants and equity but there's no evidence of procurement acceleration. Even if some DoD demand surfaces, procurement cycles are long and policy risk high; more critically, government equity creates a governance overhang that can impede fundraising, partnerships, or pivots, not just 'accelerated revenue.' The market should price in governance constraints alongside potential grants.
The panel consensus is bearish on Rigetti's stock, with the $100 million CHIPS Act grant extending runway but not guaranteeing revenue. The equity stake taken by the government is seen as a significant risk, potentially diluting shareholders and creating governance constraints.
Potential accelerated DoD procurement (speculative)
Government equity stake creating dilution and governance constraints